1. A liquid laundry detergent composition comprising:
from about 9% to about 20% by weight of the composition of a surfactant system, wherein the surfactant system comprises
a first nonionic surfactant (A), wherein A has a HLB less than 10, wherein A is selected from the group consisting of: C12,13 EO2; C12,13 EO3; and mixtures thereof;
a second nonionic surfactant (B), wherein B has a HLB greater than 10, wherein B is selected from the group consisting of: C11,16 EO7; C14,15 EO7; C12,14 EO7; C12,14 EO9; and mixtures thereof;
wherein the weight ratio of A:B is from about 1:100 to about 40:100; and
from about 2% to about 15%, by weight of the composition, of anionic surfactant, wherein the anionic surfactant comprises linear alkyl benzene sulfonic acid andor salts thereof;
wherein the composition has a neat pH of from about 1.5 to about 6.9;
wherein the composition has a viscosity of from about 200 cps to about 3000 cps measured at 20 s\u22121 at 21.1\xb0 C.;
wherein the composition further comprises from about 5% to about 15%, by weight of the composition, of an organic acid, wherein the organic acid comprises citric acid.
2. A composition according to claim 1, wherein the weight ratio of A:B is from about 15:100 to about 25:100.
3. A composition according to claim 1, wherein the composition has a neat pH of from about 2 to about 4.
4. A composition according to claim 1, wherein the composition has a viscosity of from about 200 cps to about 1500 cps measured at 20 s\u22121 at 21.1\xb0 C.
5. A composition according to claim 1, wherein the composition further comprises an organic solvent.
6. A composition according to claim 1, wherein the organic acid comprises no more than six carbons.
7. A composition according to claim 1, wherein the organic acid further comprises lactic acid, acetic acid, or mixtures thereof.
8. A composition according to claim 1, wherein the composition comprises less than 0.5%, by weight of the composition, of halide ions.
9. A composition according to claim 1, wherein the composition comprises less than about 1%, by weight of the composition, of alkanolamine.
10. A composition according to claim 1, wherein the composition comprises at least about 60% water.
11. A composition according to claim 1, wherein the ratio of anionic surfactant to nonionic surfactant is from about 1:100 to about 1:1.
12. A composition according to claim 11, wherein the ratio of anionic surfactant to nonionic surfactant is from about 40:100 to about 75:100.
13. A method for treating a surface, comprising the step of contacting the surface with the composition of claim 1.
14. A liquid laundry detergent composition comprising:
from about 2% to about 20% by weight of the composition of a surfactant system, wherein the surfactant system comprises
a first nonionic surfactant (A), wherein A has an HLB less than 10, wherein A is selected from the group consisting of: C12,13 EO2; C12,13 EO3; and mixtures thereof;
a second nonionic surfactant (B), wherein B has an HLB greater than 10, wherein B is selected from the group consisting of: C11,16 EO7; C14,15 EO7; C12,14 EO7; C12,14 EO9; and mixtures thereof;
wherein the weight ratio of A:B is from about 1:100 to about 40:100; and
from about 2% to about 15%, by weight of the composition, of anionic surfactant, wherein the anionic surfactant comprises linear alkyl benzene sulfonic acid andor salts thereof;
from about 5% to about 15%, by weight of the composition, of organic acid, wherein the organic acid comprises no more than 6 carbon atoms, and wherein the organic acid comprises citric acid;
from about 60% to about 90% water;
wherein the composition has a neat pH of from about 2 to about 4;
and wherein the composition has a viscosity of from about 200 cps to about 1200 cps measured at 20 s\u22121 at 21.1\xb0 C.
15. A composition according to claim 1, wherein the composition is substantially free of bleach, meaning that bleach has not been deliberately added to the composition.
16. A composition according to claim 1, wherein the surfactant system consists of two nonionic surfactants and one anionic surfactant.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. An implantable device comprising:
a substrate;
an adhesion layer comprising a portion with a predominant proportion of palladium, the portion of the adhesion layer with a predominant proportion of palladium directly on the substrate; and
a capping layer comprising a capping layer material, the capping layer on the adhesion layer.
2. The device of claim 1, wherein the capping layer material comprises a biocompatible material.
3. The device of claim 2, wherein the biocompatible material comprises at least one of platinum, platinum-iridium, tantalum, titanium, and alloys thereof.
4. The device of claim 2, wherein the biocompatible material comprises at least one of tin, indium, palladium, gold and alloys thereof.
5. The device of claim 1, wherein the capping layer material comprises a predominant proportion of platinum.
6. The device of claim 1, wherein the adhesion layer between the substrate and the capping layer has a thickness of less than about 5000 angstroms.
7. The device of claim 1, wherein at least one of the capping layer and the adhesion layer has a thickness between about 100 and 5000 angstroms.
8. The device of claim 7, wherein at least one of the capping layer and the adhesion layer has a thickness between about 500 and 2500 angstroms.
9. The device of claim 1, wherein the capping layer has a thickness of less than about 2500 angstroms.
10. The device of claim 1, wherein at least one of the adhesion layer and the capping layer is substantially of a density greater than about 95% full bulk density.
11. The device of claim 1, wherein at least one of the adhesion layer and the capping layer is substantially of a density equal to or greater than about 97% full bulk density.
12. The device of claim 1, wherein the substrate comprises a highly radiopaque material.
13. The device of claim 12, wherein the highly radiopaque material comprises cobalt-chromium material.
14. The device of claim 1, wherein the substrate comprises a metallic material including at least one of stainless steel, nickel-based steel, cobalt-chromium, titanium, nitinol, and alloys thereof.
15. The device of claim 1, wherein the adhesion layer comprises a first portion that is directly on the substrate and a second portion that is directly on the first portion, and wherein the second portion is between the first portion and the capping layer.
16. The device of claim 15, wherein the second portion comprises a gradated mixture of palladium and capping layer material, wherein the gradated mixture of palladium and capping layer material includes a high concentration of palladium and a low concentration of capping layer material in a region proximal to the first portion of the adhesion layer, and wherein the gradated mixture of palladium and capping layer material includes a low concentration of palladium and a high concentration of capping layer material in a region proximal to the capping layer.
17. The device of claim 1, wherein the capping layer is directly on the adhesion layer.
18. The device of claim 1, wherein the adhesion layer comprises a predominant proportion of palladium throughout its thickness.
18. The device of claim 1, wherein the capping layer material comprises a material other than palladium.
20. The device of claim 1 further comprising a polymer layer on the capping layer.
21. The device of claim 1, wherein the implantable device comprises a flexible body.
22. The device of claim 1, wherein the implantable device is an intravascular stent.
23. An implantable device comprising:
a substrate;
an adhesion layer comprising a portion with a predominant proportion of gold, the portion of the adhesion layer with a predominant proportion of gold directly on the substrate; and
a capping layer comprising a capping layer material, the capping layer on the adhesion layer, wherein the adhesion layer between the substrate and the capping layer has a thickness of less than about 5000 angstroms.
24. The device of claim 23, wherein the capping layer material comprises a biocompatible material.
25. The device of claim 24, wherein the biocompatible material comprises at least one of platinum, platinum-iridium, tantalum, titanium, and alloys thereof.
26. The device of claim 24, wherein the biocompatible material comprises at least one of tin, indium, palladium, gold and alloys thereof.
27. The device of claim 23, wherein the capping layer material comprises a predominant proportion of platinum.
28. The device of claim 23, wherein at least one of the capping layer and the adhesion layer has a thickness between about 100 and 5000 angstroms.
29. The device of claim 28, wherein at least one of the capping layer and the adhesion layer has a thickness between about 500 and 2500 angstroms.
30. The device of claim 23, wherein the capping layer has a thickness of less than about 2500 angstroms.
31. The device of claim 23, wherein at least one of the adhesion layer and the capping layer is substantially of a density greater than about 95% full bulk density.
32. The device of claim 23, wherein at least one of the adhesion layer and the capping layer is substantially of a density equal to or greater than about 97% full bulk density.
33. The device of claim 23, wherein the substrate comprises a highly radiopaque material.
34. The device of claim 33, wherein the highly radiopaque material includes cobalt-chromium material.
35. The device of claim 23, wherein the substrate comprises a metallic material including at least one of stainless steel, nickel-based steel, cobalt-chromium, titanium alloys, nitinol, and alloys thereof.
36. The device of claim 23, wherein the adhesion layer comprises a first portion that is directly on the substrate and a second portion that is directly on the first portion, and the second portion is between the first portion and the capping layer.
37. The device of claim 36, wherein the second portion comprises a gradated mixture of gold and capping layer material, wherein the gradated mixture of gold and capping layer material includes a high concentration of gold and a low concentration of capping layer material in a region proximal to the first portion of the adhesion layer, and wherein the gradated mixture of gold and capping layer material includes a low concentration of gold and a high concentration of capping layer material in a region proximal to the capping layer.
38. The device of claim 23, wherein the capping layer is directly on the adhesion layer.
39. The device of claim 23, wherein the adhesion layer comprises a predominant proportion of gold throughout its thickness.
40. A method of providing a surface on an implantable device comprising:
providing a substrate of the implantable device;
providing an adhesion layer comprising a portion with a predominant proportion of palladium directly on the substrate by simultaneously directing a flux of palladium atoms and a flux of bombarding ions toward the substrate; and
providing a capping layer comprising a capping layer material on the adhesion layer by directing a flux of capping layer material atoms and a flux of bombarding ions toward the provided adhesion layer.
41. The method of claim 40 wherein the bombarding ions are directed in substantially collinear fashion toward the substrate with respect to said fluxes of palladium or capping material atoms:
42. The method of claim 40 wherein providing the adhesion layer comprises:
providing a first portion of the adhesion layer directly on the substrate, the first portion of the adhesion layer comprising the predominant proportion of palladium; and
providing a second portion of the adhesion layer directly on the first portion, the second portion comprising a gradated mixture of palladium and capping layer material between the first portion and the capping layer.
43. The method of claim 42, wherein the gradated mixture includes a high concentration of palladium and a low concentration of capping layer material in a region proximal to the first portion of the adhesion layer by providing a greater proportion of palladium atoms than capping layer material atoms, and wherein the gradated mixture includes a low concentration of palladium and a high concentration of capping layer material in a region proximal to the capping layer by providing a greater proportion of capping layer material atoms than palladium atoms.
44. The method of claim 42, wherein the gradated mixture is provided by simultaneously directing the fluxes of palladium atoms, capping layer material atoms, and bombarding ions toward the substrate.
45. The method of claim 40, wherein forming the adhesion layer comprises using at least one magnetron to direct the fluxes of palladium atoms and the capping layer material atoms.
46. The method of claim 45, wherein the at least one magnetron comprises an unbalanced magnetron.
47. The method of claim 40, wherein the capping layer is substantially biocompatible.
48. The method of claim 40, wherein the capping layer material atoms are platinum atoms.
49. The method of claim 40, wherein the adhesion layer between the substrate and the capping layer has a thickness of less than about 5000 angstroms.
50. The method of claim 40, wherein at least one of the capping layer and the adhesion layer has a thickness between about 100 and 5000 angstroms.
51. The method of claim 40, wherein at least one of the capping layer and the adhesion layer has a thickness of less than about 2500 angstroms.
52. The method of claim 40, wherein providing the capping layer comprises forming the capping layer directly on the adhesion layer.
53. The method of claim 40, wherein providing the adhesion layer comprises providing the adhesion layer to comprise a predominant proportion of palladium throughout its thickness.
54. The method of claim 40, wherein the adhesion layer is substantially of a density greater than about 95% full bulk density.
55. The method of claim 40, wherein the capping layer is substantially of a density greater than about 95% full bulk density.
56. The method of claim 40, wherein the adhesion layer is substantially of a density equal to or greater than about 97% full bulk density.
57. The method of claim 40, wherein the capping layer is substantially of a density equal to or greater than about 97% full bulk density.
58. A method of providing a surface on an implantable device comprising:
providing a substrate of the implantable device;
providing an adhesion layer comprising a portion having a predominant proportion of gold directly on the substrate by simultaneously directing a flux of gold atoms and a flux of bombarding ions toward the substrate; and
providing a capping layer comprising a capping layer material on the adhesion layer by directing a flux of capping layer material atoms and a flux of bombarding ions toward the provided adhesion layer, the adhesion layer between the substrate and the capping layer having a thickness of less than about 5000 angstroms.
59. The method of claim 58 wherein the bombarding ions are directed in substantially collinear fashion toward the substrate with respect to said fluxes of gold atoms or capping material atoms.
60. The method of claim 58 wherein providing the adhesion layer comprises:
providing a first portion of the adhesion layer directly on the substrate, the first portion of the adhesion layer comprising the predominant proportion of gold; and
providing a second portion of the adhesion layer directly on the first portion, the second portion comprising a gradated mixture of gold and capping layer material between the first portion and the capping layer.
61. The method of claim 58, wherein the capping layer is substantially biocompatible.
62. The method of claim 58, wherein the capping layer material atoms are platinum atoms.
63. The method of claim 58, wherein at least one of the capping layer and the adhesion layer has a thickness between about 100 and 5000 angstroms.
64. The method of claim 58, wherein at least one of the capping layer and the adhesion layer has a thickness of less than about 2500 angstroms.
65. The method of claim 58, wherein providing the capping layer comprises forming the capping layer directly on the adhesion layer.
66. The method of claim 58, wherein at least one of the capping layer or adhesion layer is substantially of a density greater than about 95% full bulk density.
67. The method of claim 58, wherein at least one of the capping layer or adhesion layer is substantially of a density greater than or equal to about 97% full bulk density.
68. The device of claim 1, wherein the capping layer material consists essentially of platinum.
69. An implantable device comprising:
a substrate; and
a coating directly on the substrate, the coating comprising a capping layer of essentially platinum, wherein the coating has a thickness of less than about 15,000 angstroms.
70. The implantable device of claim 69 wherein the coating has a thickness of between about 100 and 5000 angstroms.
71. The implantable device of claim 69 wherein the coating comprises an adhesion layer with a predominant proportion of palladium, the capping layer of essentially platinum directly on the adhesion layer.
72. A method of providing a surface on an implantable device comprising:
providing a substrate; and
forming a coating directly on the substrate, the coating comprising a capping layer of essentially platinum, wherein the coating has a thickness of less than about 15,000 angstroms.